Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States

By rosaguerrero • May 9, 2022

Tenforde MW, Patel MM, Ginde AA, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, Gaglani M, McNeal T, Ghamande S, Shapiro NI, Gibbs KW, Files DC, Hager DN, Shehu A, Prekker ME, Erickson HL, Exline MC, Gong MN, Mohamed A, Henning DJ, Steingrub JS, Peltan ID, Brown SM, Martin ET, Monto AS, Khan A, Hough CL, Busse LW, Ten Lohuis CC, Duggal A, Wilson JG, Gordon AJ, Qadir N, Chang SY, Mallow C, Gershengorn HB, Babcock HM, Kwon JH, Halasa N, Chappell JD, Lauring AS, Grijalva CG, Rice TW, Jones ID, Stubblefield WB, Baughman A, Womack KN, Lindsell CJ, Hart KW, Zhu Y, Olson SM, Stephenson M, Schrag SJ, Kobayashi M, Verani JR, Self WH; Influenza and Other Viruses in the Acutely Ill (IVY) Network. Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States. Clin Infect Dis. 2022 May 3;74(9):1515-1524. doi: 10.1093/cid/ciab687. PMID: 34358310; PMCID: PMC8436392.

Tags: covid-19, immunocompromised, mRNA vaccines, Publications, Pulmonary, Critical Care & Sleep Medicine, vaccine effectiveness

Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial

Haddad R, Fayette J, Teixeira M, Prabhash K, Mesia R, Kawecki A, Dechaphunkul A, Dinis J, Guo Y, Masuda M, Hsieh CY, Ghi MG, Vaz[...]

Characterising the protective vasodilatory effects of hypobaric hypoxia on the neurovascular coupling response

Leacy JK, Burns DP, Jendzjowsky NG, Braun C, Herrington BA, Wilson RJ, Vermeulen TD, Foster GE, Rosenberg AJ, Anderson GK, Rickards CA, Lucking EF, O'Halloran[...]

Racial and Ethnic Disparities in Referral to Outpatient Heart Failure Management at Hospital Discharge: A Get With The Guidelines Analysis

Wang M, He X, Crawford K, Ko YA, Dickert NW, Patel SA, Pandey A, DeFilippis EM, Breathett K, Cogswell R, Yancy CW, Fonarow GC, Morris[...]